<PAGE>
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 7, 1995
ROBERTS PHARMACEUTICAL CORPORATION
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
New Jersey 1-10432 22-2429994
------------------ --------------- ------------------
(State or other (Commission (IRS Employer
jurisdiction File Number) Identification
of incorporation) Number)
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
--------------------------------------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: 908-389-1182
--------------------------------------------------------------------------------
(Former name or former address, if changed from last report)
<PAGE>
Item 5. Other Events
------------
The Company announced the discontinuance of the operations of
its Home Care Division and its Medical Products Division and that the Company
plans to divest certain of its non-core prescription and non-prescription
products including the products of Geriatric Pharmaceutical Corporation. The
Company stated that it was engaging in a more focused utilization of resources
to optimize growth.
The Company further announced that it would seek buyers for its
Home Care Division and its Medical Products Division as well as certain of its
non-core prescription and non-prescription products.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROBERTS PHARMACEUTICAL CORPORATION
----------------------------------
(Registrant)
Date: August 21, 1995 By: /s/ Anthony A. Rascio
------------------------------
Anthony A. Rascio
Vice President
